Use and diversion of illicit methadone - Under what circumstances does it occur, and potential risks associated with continued use of other substances

Journal of Substance Use

Volumn 19, Issue 1-2, 2014, Pages 48-55

  Duffy, Paul ^a   Mackridge, Adam John ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

Diversion; Methadone; Risks; Treatment

Indexed keywords

EID: 84894413366     PISSN: 14659891     EISSN: 14759942     Source Type: Journal    
DOI: 10.3109/14659891.2012.734539     Document Type: Article

References (87)

1. Backmund, M., Meyer, K., Henkel, C., Soyka, M., Reimer, J., & Schutz, C. G. (2005). Co-consumption of benzodiazepines in heroin users, methadone-substituted and codeine-substituted patients. Journal of Addictive Diseases, 24, 17-29.
2. Bell, J. (2010). The global diversion of pharmaceutical drugs: opiate treatment and the diversion of pharmaceutical opiates: a clinician's perspective. Addiction, 105, 1531-1537.
3. Best, D., Harris, J., Gossop, M., Farrell, M., Finch, E., Noble, A., & Strang, J. (2000). Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment. Drug and Alcohol Review, 19, 9-16.
4. Bleich, A., Gelkopf, M., Schmidt, V., Hayward, R., Bodner, G., & Adelson, M. (1999). Correlates of benzodiazepine abuse in methadone maintenance treatment. A 1 year prospective study in an Israeli clinic. Addiction, 94, 1533-1540.
5. Bloor, M., McIntosh, J., McKeganey, N., & Robertson, M. (2008). 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users. Public Health, 122, 1013-1019.
6. Bourke, D. L., Malit, L. A., & Smith, T. C. (1987). Respiratory interactions of ketamine and morphine. Anesthesiology, 66, 153-156.
7. Brache, K., Stockwell, T., & Macdonald, S. (2011). Functions and harms associated with simultaneous polysubstance use involving alcohol and cocaine. Journal of Substance Use, Early Online, 1-18.
8. Brands, B., Blake, J., Marsh, D. C., Sproule, B., Jeyapalan, R., & Li, S. (2008). The impact of benzodiazepine use on methadone maintenance treatment outcomes. Journal of Addictive Diseases, 27, 37-48.
9. Brandt, S. D., Sumnall, H. R., Measham, F., & Cole, J. (2010). Analyses of second-generation "legal highs" in the UK: initial findings. Drug Testing and Analysis, 2, 377-382.
10. Caplehorn, J. (1996). Risk factors for non-HIV-related death among methadone maintenance patients. European Addiction Research, 2, 49-52.
11. Chan, G. M., Stajic, M., Marker, E. K., Hoffman, R. S., & Nelson, L. S. (2006). Testing positive for methadone and either a tricyclic antidepressant or a benzodiazepine is associated with an accidental overdose death: analysis of medical examiner data. Academic Emergency Medicine, 13, 543-547.
12. Corkery, J., Schifano, F., Ghodse, H., & Oyefeso, A. (2004). The effects of methadone and its role in fatalities. Human Psychopharmacology: Clinical and Experimental, 19, 565-576.
13. Cousins, E., Teljeur, C., Motterlini, N., McCowan, C., Dimitrov, B. D., & Fahey, T. (2011). Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study. Journal of Substance Abuse Treatment, 41, 252-260.
14. Darke, S., Swift, W., Hall, W., & Ross, M. (1993). Drug-use, HIV risktaking and psychosocial correlates of benzodiazepine use among methadone-maintenance clients. Drug and Alcohol Dependence, 34, 67-70.
15. Darke, S., Hall, W., Weatherburn, D. & Lind, B. (1999). Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug and Alcohol Dependence, 54, 155-161.
16. Davis, W., & Johnson, B. (2008). Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug and Alcohol Dependence, 92, 267-276.
17. Department of Health (England) and the devolved administrations (2007). Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive.
18. Dobler-Mikola, A., Hättenschwiler, J., Meili, D., Beck, T., Böni, E., & Modestin, J. (2005). Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. Journal of Substance Abuse Treatment, 29, 259-265.
19. Drake, W. M., & Broadhurst, P. A. (1996). QT-interval prolongation with Ecstasy. South African Medical Journal, 86, 180-181.
20. Duffy, P., & Baldwin, H. (2012). The nature of methadone diversion in England: a merseyside case study. Harm Reduction Journal, 9, 3.
21. Edmunds, M., Hough, M., & Urquía, N. (1996). Tackling local drug markets. London: Home Office.
22. Eiroa-Orosa, F. J., Haasen, C., Verthein, U., Dilg, C., Schäfer, I.,&Reimer, J. (2010). Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial. Drug and Alcohol Dependence, 112, 226-233.
23. Elsayem, A., & Bruera, E. (2005). Methadone-induced respiratory depression in a patient with a history of alcoholism. Journal palliative medicine, 8, 1062-1066.
24. Epstein, D. H., Schmittner, J., Umbricht, A., Schroeder, J. R., Moolchan, E. T., & Preston, K. L. (2009). Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency. Drug and Alcohol Dependence, 101, 92-100.
25. Evans, J. L., Hahn, J. A., Lum, P. J., Stein, E. S., & Page, K. (2009). Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug and Alcohol Dependence, 101, 152-157.
26. Farré, M., de la Torre, R., González, M. L., Terán, M. T., Roset, P. N., Menoyo, E., & Camí, J. (1997). Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism. Journal of Pharmacology and Experimental Therapeutics, 283, 164-176.
27. Farre, M., Mas, A., Torrens, M., Moreno, V., & Cami, J. (2002). Retention rate and illicit opioid use during methadone maintenance interventions, a meta-analysis. Drug and Alcohol Dependence, 65, 283-290.
28. Foltin, R. W., Christiansen, I., Levin, F. R., & Fischman, M. W. (1995). Effects of single and multiple intravenous cocaine injections in humans maintained on methadone. Journal of Pharmacology and Experimental Therapeutics, 275, 38-47.
29. Forman, R. F., Marlowe, D. B., & McLellan, A. T. (2006). The internet as a source of drugs of abuse. Current Psychiatry Reports, 8, 377-382.
30. Fountain, J., Griffiths, P., Farrell, M., Gossop, M., & Strang, J. (1999). Benzodiazepines in polydrug-using repertoires: the impact of the decreased availability of temazepam gel-filled capsules. Drug- Education Prevention and Policy, 6, 61-69.
31. Fountain, J., Strang, J., Gossop, M., Farrel, M., & Griffiths, P. (2000). Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction, 95, 393-406.
32. Gelkopf, M., Bleich, A., Hayward, R., Bodner, G., & Adelson, M. (1999). Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic. Drug and Alcohol Dependence, 55, 63-68.
33. Gossop, M., Stewart, D., Browne, N., & Marsden, J. (2003). Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: outcomes at 2-year follow-up. Journal of Substance Abuse Treatment, 24, 313-321.
34. Grab, H., Behnsen, S., Kimont, H. G., Staak, M., & Käferstein, H. (2003). Methadone and its role in drug-related fatalities in Cologne 1989-2000. Forensic Science International, 132, 195-200.
35. Graham, N. A., Merlo, L. J., Goldberger, B. A., & Gold, M. S. (2008). Methadone and heroin-related deaths in Florida. The American Journal of Drug and Alcohol Abuse, 34, 347-353.
36. Hall, W., & Degenhardt, L. (2007). Regulating opioid prescribing to provide access to effective treatment while minimizing diversion: an overdue topic for research. Addiction, 102, 1685-1688.
37. Hay, G., Gannon, M., Casey, J., & Millar, T. (2009). Estimates of the prevalence of opiate use and/or crack cocaine use (2008/09) North West Region. London: Home Office.
38. Heinemann, A., Iwersen-Bergmann, S., Stein, S., Schmoldt, A., & Püschel, K. (2000). Methadone-related fatalities in Hamburg 1990-1999: implications for quality standards in maintenance treatment? Forensic Science International, 113, 449-455.
39. Inciardi, J. A., Surratt, H. L., Kurtz, S. P., & Cicero, T. J. (2007). Mechanisms of prescription drug diversion among drug-involved club and street-based populations. Pain Medicine, 8, 171-183.
40. Johnstone, R. E., Lief, P. L., Kulp, R. A., & Smith, T. C. (1975). Combination of delta9-tetrahydrocannabinol with oxymorphone or pentobarbital. Effects on ventilatory control and cardiovascular dynamics. Anesthesiology, 42, 674-684.
41. Kerr, T., Fairbairn, N., Tyndall, M., Marsh, D., Li, K., Montaner, J., & Wood, E. (2007). Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug and Alcohol Dependence, 87, 39-45.
42. King, V. L., Stoller, K. B., Hayes, M., et al. (2002). A multicenter randomized evaluation of methadone medical Maintenance. Drug and Alcohol Dependence, 65, 137-148.
43. Krantz, M. J., Rowan, S. B., & Mehler, P. S. (2005). Cocaine-related torsade de pointes in a methadone maintenance patient. Journal of Addictive Diseases, 24, 53-60.
44. Laberke, P. J., & Bartsch, C. (2010). Trends in methadone-related deaths in Zurich. International Journal of Legal Medicine, 124, 381-385.
45. Lauzon, P., Vincelette, J., Bruneau, J., Lamothe, F., Lachance, N., Brabant, M., & Soto, J. (1994). Illicit use of methadone among IV drug users in Montreal. Journal of Substance Abuse Treatment, 11, 457-461.
46. Li, L., Sangthong, R., Chongsuvivatwong, V., McNeil, E., & Li, J. (2011). Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China. Drug and Alcohol Dependence, 116, 246-249.
47. Lin, C., Wu, Z., & Detels, R. (2011). Family support, quality of life and concurrent substance use among methadone maintenance therapy clients in China. Public Health, 125, 269-274.
48. Long, J. (2010). Adulterants, bulking agents and contaminants in illicit drugs. Drugnet Ireland, 35, 18-20.
49. Madden, M. E., & Shapiro, S. L. (2011). The methadone epidemic: methadone-related deaths on the rise in Vermont. The American Journal of Forensic Medicine and Pathology, 32, 131-135.
50. Man, L., Best, D., Gossop, M., Stillwell, G., & Strang, J. (2004). Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment. European Addiction Research, 10, 35-40.
51. Matheson, C., Bond, C., & Hickey, F. (1999). Prescribing and dispensing for drug misusers in primary care: current practice in Scotland. Family Practice, 1, 375-379.
52. Musshoff, F., Trafkowski, J., Lichtermann, D., & Madea, B. (2010). Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs. International Journal of Legal Medicine, 124, 499-503.
53. National Institute for Health and Clinical Excellence. (2007). Methadone and buprenorphine for the management of opioid dependence. Retrieved 25 February 2011 from http://www.nice.org.uk/TA114
54. Neale, J. (1999). Drug users' views of substitute prescribing conditions. International Journal of Drug Policy, 10, 247-258.
55. Neale, J. (2000). Methadone, methadone treatment and non-fatal overdose. Drug and Alcohol Dependence, 58, 117-124.
56. Nyamathi, A., Cohen, A., Marfisee, M., Shoptaw, S., Greengold, B., de Castro, V., George, D., & Leake, B. (2009). Correlates of alcohol use among methadone-maintained adults. Drug and Alcohol Dependence, 101, 124-127.
57. Office for National Statistics. (2011). Mid-year population estimates 2010: 30/06/11. Retrieved 10 August 2011 from http://www.statistics.gov.uk/ statbase/Product.asp?vlnk=15106
58. Parker, H., & Kirby, P. (1996). Methadone maintenance and crime reduction on merseyside. London: Home Office Police Research Group.
59. Parrott, A. C.,Milani, R.M., Gouzoulis-Mayfrank, E.,&Daumann, J. (2007). Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. Journal of Neural Transmission, 114, 959-968.
60. Pennings, E. J. M., Wolff F. A., & Leccese, A. P. (2002). Effects of concurrent use of alcohol and cocaine. Addiction, 97, 773-783.
61. Pirnay, S., Borron, S., Giudicelli, C., Tourneau, J., Baud, F., & Ricordel, I. (2004). A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction, 99, 978-988.
62. Raffa, J. D., Grebely, J., Tossonian, H., et al. (2007). The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Drug and Alcohol Dependence, 89, 306-309.
63. Risser, D., Honigschnabl, S., Stichenwirth, M., Pfudl, S., Sebald, D., Kaff, A., & Bauer, G. (2001). Mortality of opiate users in Vienna, Austria. Drug and Alcohol Dependence, 64, 251-256.
64. Roche, A., McCabe, S., & Smyth, B. P. (2008). Illicit methadone use and abuse in young people accessing treatment for opiate dependence. European Addiction Research, 14, 219-225.
65. Ryder, N., Cullen, W., Barry, J., Bury, G., Keenan, E., & Smyth, B. P. (2009). Prevalence of problem alcohol use among patients attending primary care for methadone treatment. BMC Family Practice, 10, 42-52.
66. Schiff, M., Levit, S., & Moreno, R. C. (2007). Retention and illicit drug use among methadone patients in Israel: a gender comparison. Addictive Behaviors, 32, 2108-2119.
67. Schreiber, S., Peles, E., & Adelson, M. (2008). Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients. Drug and Alcohol Dependence, 92, 79-85.
68. Seymour, A., Black, M., Jay, J., Cooper, G., Weir, C., & Oliver, J. (2003). The role of methadone in drug-related deaths in the west of Scotland. Addiction, 98, 995-1002.
69. Simonsen, K. W., Hansen, C. A., Rollmann, D., Kringsholm, B., Breum Müller, I., Johansen, S. S., & Linnet, K. (2011). Drug-related death in Denmark in 2007. Danish Medical Bulletin, 58, A4307.
70. Smith, J., & Guly, H. (2004). Nalbuphine and slow release morphine. British Medical Journal, 328, 1426.
71. Stapleton, R. D., & Comiskey, C. M. (2010). Alcohol usage and associated treatment outcomes for opiate users entering treatment in Ireland. Drug and Alcohol Dependence, 107, 56-61.
72. Stastny, D., & Potter, M. (1991). Alcohol abuse by patients undergoing methadone treatment programmes. British Journal of Addiction, 86, 307-310.
73. Stenbacka, M., Beck, O., Leifman, A., Romelsjö, A., & Helander, A. (2007). A Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. Drug and Alcohol Review, 26, 55-63.
74. Stitzer, M. L., Griffiths, R. R.,Mclellan, A. T., Grabowski, J., & Hawthorne, J. W. (1981). Diazepam use among methadone-maintenance patients - patterns and dosages. Drug and Alcohol Dependence, 8, 189-199.
75. Strang, J., & Sheridan, J. (2001). Methadone prescribing to opiate addicts by private doctors: comparison with NHS practice in south east England. Addiction, 96, 567-576.
76. Strang, J., Manning, V., Mayet, S., et al. (2008). Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction, 103, 1648-1657.
77. Strang, J., Sheridan, J., Hunt, C., Kerr, B., Gerada, C., & Pringle, M. (2005). The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales. British Journal of General Practice, 55, 444-451.
78. Strupp, M., Hamann, G. F., & Brandt, T. (2000). Combined amphetamine and cocaine abuse caused mesencephalic ischemia in a 16-year-old boy - due to vasospasm? European Neurology, 43, 181-182.
79. Van Ameijden, E., Langendam, E., & Coutinho, R. (1999). Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs. Addictive Behaviors, 24, 559-563.
80. Vigezzi, P., Guglielmino, L., Marzorati, P., et al. (2006). Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients. Journal of Substance Abuse Treat, 31, 3-7.
81. Vlahov, D., O'Driscoll, P., Mehta, S. H., Ompad, D. C., Gern, R., Galai, N., & Kirk, G. D. (2007). Risk factors for methadone outside treatment programs: implications for HIV treatment among injection drug users. Addiction, 102, 771-777.
82. Wedekind, D., Jacobs, S., Karg, I., et al. (2010). Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with l- and d,lmethadone. World Journal of Biological Psychiatry, 11, 390-399.
83. Weinrich, M., & Stuart, M. (2000). Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy. Journal of the American Medical Association, 283, 1343-1348.
84. Weschules, D. J., Bain, K. T., & Richeimer, S. (2008). Actual and potential drug interactions associated with methadone. Acute Pain, 10, 101-102.
85. Williamson, A., Darke, S., Ross, J., & Teesson, M. (2006). The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence. Drug and Alcohol Dependence, 81, 293-300.
86. Winstock, A. R., Lea, T., & Sheridan, J. (2008). Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. International Journal of Drug Policy, 19, 450-458.
87. Wolf, B. C., Lavezzi, W. A., Sullivan, L. M., & Flannagan, L. M. (2005). One hundred seventy two deaths involving the use of oxycodone in Palm Beach County. Journal of Forensic Science, 50, 192-195.